+1 650 843 5365 gkang@cooley.com
Gea Kang practices general corporate law, with an emphasis on representing emerging growth companies, public companies and venture capital funds.
Download full bio
Eiger BioPharmaceuticals: $49 Million Follow-On
Cytokinetics: $138 Million Convertible Senior Notes
PagerDuty – $250 Million IPO
Harvard Law SchoolJD, 2016
Stanford UniversityBA, with distinction, 2011
California
Nanometrics Signs Agreement for Merger of Equals Combination With Rudolph Technologies June 25, 2019
SoftBank Vision Fund Leads $400 Million Series F for Compass October 1, 2018
Helix – $200 Million Series B July 9, 2018
View all
+1 650 843 5365 office gkang@cooley.com
3175 Hanover StreetPalo Alto, CA 94304-1130